retatrutide clinical benefits Perceived of treatment for obesity with retatrutide: A qualitative study of patients in a phase 2 trial Retatrutide Explained: Benefits, Mechanism &

BOLD responses Due to the temporal resolution of PET, the identification of DA release to errors was confined to the reversal period, where errors are maximized across participants

JAMA Surg 2024;159:660-7.ArticlePubMedPMC 20

However, an important distinction often gets overlooked: GLP-1 medications are not approved for Type 1 diabetes and in this population, they may increase the risk of a dangerous complication called euglycemic diabetic ketoacidosis (DKA)

Hear lots more on his progress (below): Reactions

The weighted incidence of suicidality was 4.3 and 4.6 for every 1,000 person-years in individuals prescribed GLP-1 receptor agonists and SGLT-2 inhibitors, respectively

In my first month I achieved more weight loss than any other program I have tried.** I was about to just give up